sec filing
NASDAQ · VERU
Veru Inc.
Healthcare · Biotechnology
$2.19
Down-$0.03 (-1.37%)
Updated Nov 2, 2026, 3:48 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 37.07M
- P/E ratio
- -1.13
- Dividend yield
- 0.00%
- 52-week range
- $2.05 – $7.33
- Volume
- 78.95K
- Avg. volume
- 159K
Price performance · VERU
VERU price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
VERU closed at $2.19 after 20 trading sessions, down 14.12% for the selected period.
- Last close
- $2.19
- Period change
- -14.12%
- Period low
- $2.13
- Period high
- $2.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $2.25 | $2.26 | $2.1599 | $2.19 | 78.95K |
| Oct 29, 2026 | $2.27 | $2.33 | $2.22 | $2.23 | 56.94K |
| Oct 28, 2026 | $2.27 | $2.30 | $2.24 | $2.27 | 78.17K |
| Oct 27, 2026 | $2.22 | $2.37 | $2.22 | $2.28 | 157.71K |
| Oct 26, 2026 | $2.25 | $2.26 | $2.18 | $2.21 | 86.58K |
| Oct 23, 2026 | $2.29 | $2.32 | $2.22 | $2.24 | 122.59K |
| Oct 22, 2026 | $2.30 | $2.30 | $2.24 | $2.29 | 85.82K |
| Oct 21, 2026 | $2.37 | $2.41 | $2.28 | $2.30 | 99.81K |
| Oct 20, 2026 | $2.31 | $2.40 | $2.31 | $2.38 | 89.88K |
| Oct 19, 2026 | $2.30 | $2.35 | $2.27 | $2.31 | 88.14K |
| Oct 16, 2026 | $2.41 | $2.4827 | $2.27 | $2.30 | 306.5K |
| Oct 15, 2026 | $2.14 | $2.48 | $2.12 | $2.44 | 505.36K |
| Oct 14, 2026 | $2.26 | $2.29 | $2.11 | $2.13 | 275.21K |
| Oct 13, 2026 | $2.41 | $2.415 | $2.18 | $2.19 | 170.76K |
| Oct 12, 2026 | $2.44 | $2.45 | $2.40 | $2.405 | 85.52K |
| Oct 9, 2026 | $2.42 | $2.49 | $2.42 | $2.46 | 128.9K |
| Oct 8, 2026 | $2.44 | $2.5189 | $2.39 | $2.42 | 147.63K |
| Oct 7, 2026 | $2.42 | $2.54 | $2.41 | $2.46 | 203.38K |
| Oct 6, 2026 | $2.54 | $2.75 | $2.44 | $2.47 | 1.52M |
| Oct 5, 2026 | $2.51 | $2.62 | $2.50 | $2.55 | 88.77K |
Latest VERU news
The latest Smart Investors Daily articles mentioning VERU.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…